Seeking Alpha

Merck (MRK -0.4%) says it will acquire Inspire Pharmaceuticals (ISPH), a developer of ophthalmic...

Merck (MRK -0.4%) says it will acquire Inspire Pharmaceuticals (ISPH), a developer of ophthalmic products, in an all-cash deal for $5/share, or ~$430M. The offer represents a 26% premium to yesterday's closing price. Trading in ISPH halted. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|